Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s largest consumer health companies, Kimberly-Clark said it would acquire all of Kenvue’s common stock, creating a conglomerate that will generate annual revenue of$32bn. According to the deal, shareholders in Kenvue – a company that J&J siphoned off in 2023 – will receive $3.50 per share, as well as 0.14625 of Kimberly-Clark shares for each Kenvue share held at closing. The total cons ...